29 min listen
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
ratings:
Length:
61 minutes
Released:
Aug 23, 2023
Format:
Podcast episode
Description
Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy.
CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/ERPositivemBC).
CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/ERPositivemBC).
Released:
Aug 23, 2023
Format:
Podcast episode
Titles in the series (100)
Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber: Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations. by Oncology Today with Dr Neil Love